Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9209893 | 0.91 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL9067644 | 0.91 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL15835905 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL9578999 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL21652434 | 0.84 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL11501106 | 0.83 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL20274390 | 0.83 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2MAPTPOLBTRPM8 | |
| SCHEMBL12512325 | 0.83 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL12511464 | 0.83 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2MAPTPOLBTSHR | |
| SCHEMBL8033183 | 0.82 | ALDH1A1 (0.47) | ALDH1A1MAPTTSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024085786-A1 | MEDIUM AND DEVICE FOR COLLECTING, STORING AND TRANSPORTING | Gra Olga Alekseevna (RU) | 2024-04-25 | — | — | WO | claimed |
| EP-4356731-A1 | MEDIUM AND DEVICE FOR COLLECTING, STORING AND TRANSPORTING BIOLOGICAL SAMPLES, AS WELL AS THEIR USE FOR THE STABILIZATION OF EXTRACELLULAR NUCLEIC ACIDS | Gra, Olga Alekseevna (RU) | 2024-04-24 | — | — | EP | claimed |
| EP-3401406-B1 | STABILISATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | PREANALYTIX GMBH (CH) | 2023-11-29 | — | — | EP | claimed |
| EP-3377645-B1 | METHOD OF PREPARING STERILIZED COMPOSITIONS FOR STABILIZATION OF EXTRACELLULAR NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2023-10-04 | — | — | EP | claimed |
| EP-4219747-A2 | METHOD OF PREPARING STERILIZED COMPOSITIONS FOR STABILIZATION OF EXTRACELLULAR NUCLEIC ACIDS | PreAnalytiX GmbH (CH) | 2023-08-02 | — | — | EP | claimed |
| EP-4218411-A2 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | QIAGEN GmbH (DE) | 2023-08-02 | — | — | EP | claimed |
| US-11203777-B2 | Method of preparing sterilized compositions for stabilization of extracellular nucleic acids | QIAGEN GMBH (DE) | 2021-12-21 | — | — | US | claimed |
| WO-2021058692-A1 | MULTIMODAL ANALYSIS OF STABILIZED CELL-CONTAINING BODILY FLUID SAMPLES | QIAGEN GMBH (DE) | 2021-04-01 | — | — | WO | claimed |
| EP-3447141-B1 | STABILISATION OF BIOLOGICAL SAMPLES | PREANALYTIX GMBH (CH) | 2020-08-05 | — | — | EP | claimed |
| US-10724074-B2 | Stabilisation of biological samples | QIAGEN GMBH (DE) | 2020-07-28 | — | — | US | claimed |
| EP-2976425-A1 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | Qiagen GmbH (DE) | 2016-01-27 | — | — | EP | claimed |
| EP-2976426-A1 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | Qiagen GmbH (DE) | 2016-01-27 | — | — | EP | claimed |
| US-20150275268-A1 | STABILISATION OF BIOLOGICAL SAMPLES | QIAGEN GMBH (DE) | 2015-10-01 | — | — | US | claimed |
| WO-2015140218-A1 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2015-09-24 | — | — | WO | claimed |
| EP-2900834-A1 | STABILISATION OF BIOLOGICAL SAMPLES | Qiagen GmbH (DE) | 2015-08-05 | — | — | EP | claimed |
| WO-2014146780-A1 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2014-09-25 | — | — | WO | claimed |
| WO-2014146781-A1 | STABILISATION OF BIOLOGICAL SAMPLES | QIAGEN GMBH (DE) | 2014-09-25 | — | — | WO | claimed |
| WO-2014146782-A1 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2014-09-25 | — | — | WO | claimed |
| EP-0225143-A2 | The production of ethylene-derived chemicals from gaseous paraffins | The British Petroleum Company p.l.c. (GB) | 1987-06-10 | — | — | EP | claimed |
| US-4426375-A | DIALLYLAMINE DERIVATIVES | L'OREAL (FR) | 1984-01-17 | — | — | US | claimed |